Eileen Tran
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Poxvirus research and outbreaks
Papers in
-
- Protein Degradation and Inhibitors 3
- Kruppel-like factors research 2
- Histone Deacetylase Inhibitors Research 2
- RNA modifications and cancer 1
-
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Philip P. Chamberlain (2 shared papers)Mary E. Matyskiela (2 shared papers)Scott J. Novick (1 shared paper)Jin‐Yi Zhu (1 shared paper)Gabriel C. Lander (1 shared paper)Andres Hernandez de la Peña (1 shared paper)Edmond R. Watson (1 shared paper)Patrick R. Griffin (1 shared paper)
- Journals
- Science (2 papers)MMWR Morbidity and Mortality Weekly Report (1 paper)Blood (1 paper)Nature (1 paper)Nature Structural & Molecular Biology (1 paper)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
Eileen Tran
10 papers receiving 493 citations
Eileen Tran's Hit Papers
Peers
Comparison fields: 5 of 47
- Hematology 100
- Virology 31
- Molecular Biology 408
- Oncology 130
- Cancer Research 23
Countries citing papers authored by Eileen Tran
This map shows the geographic impact of Eileen Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Tran more than expected).
Fields of papers citing papers by Eileen Tran
This network shows the impact of papers produced by Eileen Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Tran. The network helps show where Eileen Tran may publish in the future.
Co-authors
The 24 scholars most cited alongside Eileen Tran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 163 | |
| 2 | 2022 | 140 | |
| 3 | 2020 | 75 | |
| 4 | Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase Hit paper breakdown → | 2024 | 73 |
| 5 | 2022 | 29 | |
| 6 | 2021 | 9 | |
| 7 | 2023 | 9 | |
| 8 | 2021 | 6 | |
| 9 | 2025 | 6 | |
| 10 | 2025 | 6 |
About Eileen Tran
Eileen Tran is a scholar working on Molecular Biology, Hematology, Cancer Research, Virology and Pathology and Forensic Medicine, having authored 10 papers that have together received 516 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), Kruppel-like factors research (2 papers), Cancer-related molecular mechanisms research (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Multiple Myeloma Research and Treatments (2 papers), MicroRNA in disease regulation (1 paper), Poxvirus research and outbreaks (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Hematology (100 citations), Virology (31 citations), Molecular Biology (408 citations), Oncology (130 citations) and Cancer Research (23 citations). Eileen Tran has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include Philip P. Chamberlain, Mary E. Matyskiela, Scott J. Novick, Jin‐Yi Zhu, Gabriel C. Lander, Andres Hernandez de la Peña, Edmond R. Watson, Patrick R. Griffin, Ingrid E. Wertz and Xinde Zheng. Their work appears in journals such as Science, MMWR Morbidity and Mortality Weekly Report, Blood, Nature and Nature Structural & Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.